Kojiro Shimozuma

Summary

Affiliation: Ritsumeikan University
Country: Japan

Publications

  1. doi request reprint Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
    Kojiro Shimozuma
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1 1 1 Noji higashi, Kusatsu, Shiga 525 8577, Japan
    Support Care Cancer 20:3355-64. 2012
  2. doi request reprint Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
    Kojiro Shimozuma
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1 1 1 Noji higashi, Kusatsu, Shiga, 525 8577, Japan
    Support Care Cancer 17:1483-91. 2009
  3. doi request reprint Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trial
    Takeru Shiroiwa
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Shiga, Japan
    Value Health 14:746-51. 2011
  4. doi request reprint Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial
    Takeru Shiroiwa
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Shiga, Japan
    Value Health 15:255-60. 2012

Detail Information

Publications4

  1. doi request reprint Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
    Kojiro Shimozuma
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1 1 1 Noji higashi, Kusatsu, Shiga 525 8577, Japan
    Support Care Cancer 20:3355-64. 2012
    ....
  2. doi request reprint Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
    Kojiro Shimozuma
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1 1 1 Noji higashi, Kusatsu, Shiga, 525 8577, Japan
    Support Care Cancer 17:1483-91. 2009
    ..The aim of the study was to determine the feasibility and validity of a newly developed patient-based instrument--the Patient Neurotoxicity Questionnaire (PNQ)--for grading chemotherapy-induced peripheral neuropathy (CIPN)...
  3. doi request reprint Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trial
    Takeru Shiroiwa
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Shiga, Japan
    Value Health 14:746-51. 2011
    ..We also investigated the relationship between Functional Assessment of Cancer Therapy (FACT) scale scores and EQ-5D utilities...
  4. doi request reprint Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial
    Takeru Shiroiwa
    Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Shiga, Japan
    Value Health 15:255-60. 2012
    ..To evaluate the cost-effectiveness of adjuvant FOLFOX therapy versus 5-fluorouracil/leucovorin (FU/LV) for patients with stage III colorectal cancer...